Inactivation of SARS-CoV-2 on Surfaces by Cold-Plasma-Generated Reactive Species

A Cold Atmospheric Plasma (CAP) apparatus was designed and developed for SARS-CoV-2 killing as evaluated by pseudotyped viral infectivity assays. The reactive species generated by the plasma system was fully characterized by using Optical Emission Spectroscopy (OES) measurement under given conditions such as plasma power, flow rate, and treatment time. A variety of reactive oxygen species (ROS) and reactive nitrogen species (RNS) were identified from plasma plume with energies of 15–72 eV in the frequency range between 500–1000 nm. Systematic virus killing experiments were carried out, and the efficacy of CAP treatment in reducing SARS-CoV-2 viral infectivity was significant following treatment for 8 s, with further enhancement of killing upon longer exposures of 15–120 s. We correlated killing efficacy with the reactive species in terms of type, intensity, energy, and frequency. These experimental results demonstrate effective cold plasma virus killing via ROS and RNS under ambient conditions.

[1]  Linos Hadjihannas,et al.  Effect of Cold Atmospheric Plasma on SARS-CoV-2 Inactivation: A Pilot Study in the Hospital Environment , 2022, COVID.

[2]  R. Wirz,et al.  Cold atmospheric plasma for addressing the COVID‐19 pandemic , 2022, Plasma processes and polymers.

[3]  Xiaofeng Dai,et al.  Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry , 2022, Theranostics.

[4]  N. Kaushik,et al.  The inactivation and destruction of viruses by reactive oxygen species generated through physical and cold atmospheric plasma techniques: Current status and perspectives , 2022, Journal of Advanced Research.

[5]  E. Gomez-Casado,et al.  Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media , 2022, Scientific Reports.

[6]  E. Gomez-Casado,et al.  Vulnerability of SARS-CoV-2 and PR8 H1N1 virus to cold atmospheric plasma activated media , 2022, Scientific reports.

[7]  A. Paglianti,et al.  Cold atmospheric plasma decontamination of SARS‐CoV‐2 bioaerosols , 2021, Plasma Processes and Polymers.

[8]  A. Assadi,et al.  Review on inactivation of airborne viruses using non-thermal plasma technologies: from MS2 to coronavirus , 2021, Environmental Science and Pollution Research.

[9]  N. Joshi,et al.  Cold plasma technology: advanced and sustainable approach for wastewater treatment , 2021, Environmental Science and Pollution Research.

[10]  M. Keidar,et al.  Multi-Modal Biological Destruction by Cold Atmospheric Plasma: Capability and Mechanism , 2021, Biomedicines.

[11]  F. Krebs,et al.  Non-Thermal Plasma as a Novel Strategy for Treating or Preventing Viral Infection and Associated Disease , 2021, Frontiers in Physics.

[12]  R. Wirz,et al.  Cold atmospheric plasma for SARS-CoV-2 inactivation , 2020, Physics of fluids.

[13]  Marc C. Johnson,et al.  Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein , 2020, Journal of Virology.

[14]  E. Choi,et al.  Cold atmospheric plasma generated reactive species aided inhibitory effects on human melanoma cells: an in vitro and in silico study , 2020, Scientific Reports.

[15]  A. Sakudo,et al.  Disinfection and Sterilization Using Plasma Technology: Fundamentals and Future Perspectives for Biological Applications , 2019, International journal of molecular sciences.

[16]  M. Roopesh,et al.  Cold Plasma for Effective Fungal and Mycotoxin Control in Foods: Mechanisms, Inactivation Effects, and Applications. , 2018, Comprehensive reviews in food science and food safety.

[17]  Jalil Ali,et al.  Plasma Kinetic Theory , 2017 .

[18]  Liying Xing,et al.  Comparison of three quantification methods for the TZM-bl pseudovirus assay for screening of anti-HIV-1 agents. , 2016, Journal of virological methods.

[19]  Francis F. Chen,et al.  Introduction to Plasma Physics and Controlled Fusion , 2015 .

[20]  G. Donnarumma,et al.  Bacterial inactivation/sterilization by argon plasma treatment on contaminated titanium implant surfaces:In vitro study , 2015, Medicina oral, patologia oral y cirugia bucal.

[21]  P. Chu,et al.  Low Temperature Plasma Technology : Methods and Applications , 2013 .

[22]  C. Nathan,et al.  Beyond oxidative stress: an immunologist's guide to reactive oxygen species , 2013, Nature Reviews Immunology.

[23]  M. Brown,et al.  Plasma Physics: An Introduction to Laboratory, Space, and Fusion Plasmas , 2011 .

[24]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[25]  Z. Ren,et al.  Enhanced thermal stability of carbon nanotubes by plasma surface modification in Al2O3 composites , 2008 .

[26]  Z. Ren,et al.  Effects of plasma surface modification on interfacial behaviors and mechanical properties of carbon nanotube-Al2O3 nanocomposites , 2007 .

[27]  D. Montefiori,et al.  Induction of Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 Primary Isolates by Gag-Env Pseudovirion Immunization , 2005, Journal of Virology.

[28]  G. Beaucage,et al.  How does surface modification aid in the dispersion of carbon nanofibers? , 2005, The journal of physical chemistry. B.

[29]  M. Schulz,et al.  Plasma coating of carbon nanofibers for enhanced dispersion and interfacial bonding in polymer composites , 2003 .

[30]  Jie Lian,et al.  Plasma deposition of Ultrathin polymer films on carbon nanotubes , 2002 .

[31]  D. Shi,et al.  Interfacial Particle Bonding Via an Ultrathin Polymer Film on Al_2O_3 Nanoparticles by Plasma Polymerization , 2002 .

[32]  D. Shi,et al.  Uniform deposition of ultrathin polymer films on the surfaces of Al2O3 nanoparticles by a plasma treatment , 2001 .

[33]  W. MacNee,et al.  Oxidative stress and regulation of glutathione in lung inflammation. , 2000, The European respiratory journal.

[34]  M. Rong,et al.  Using cold atmospheric plasma treated-air for COVID-19 disinfection in cold-chain environment , 2021 .

[35]  Sunarso,et al.  Surface plasma treatment and phosphorylation enhance the biological performance of poly(ether ether ketone). , 2019, Colloids and surfaces. B, Biointerfaces.